Pulmonary and psoas muscle nocardiosis in a patient with lupus nephritis: A case report and review of the literature

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

The incidence of nocardiosis is increasing with the expansion of immunosuppressive therapy and improvement of laboratory diagnostic methods. Nocardiosis could be fatal in the compromised host. Some Nocardia species are known to be multi-drug resistant. Thus, early recognition and identification of Nocardia species are important for patient treatment and outcome. Recently, we treated a patient with pulmonary and psoas muscle nocardiosis in a woman taking prednisolone for lupus nephritis; the isolated organism was Nocardia farcinica identified by polymerase chain reaction-restriction fragment length polymorphism testing.

Original languageEnglish
Pages (from-to)929-936
Number of pages8
JournalRheumatology International
Volume31
Issue number7
DOIs
Publication statusPublished - 2011 Jul

Keywords

  • Lupus nephritis
  • Nocardiosis
  • Prednisolone
  • Psoas muscle
  • Pulmonary

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Pulmonary and psoas muscle nocardiosis in a patient with lupus nephritis: A case report and review of the literature'. Together they form a unique fingerprint.

  • Cite this